Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
Crossref DOI link: https://doi.org/10.1186/s13075-016-1150-7
Published Online: 2016-10-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miner, Jeffrey N.
Tan, Philip K.
Hyndman, David
Liu, Sha
Iverson, Cory
Nanavati, Payal
Hagerty, David T.
Manhard, Kimberly
Shen, Zancong
Girardet, Jean-Luc
Yeh, Li-Tain
Terkeltaub, Robert
Quart, Barry